1/24
06:29 am
pgen
Precigen (NASDAQ:PGEN) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Precigen (NASDAQ:PGEN) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/20
08:05 am
pgen
New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
Low
Report
New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
1/12
08:00 am
pgen
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
1/5
05:02 pm
pgen
Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
High
Report
Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
04:05 pm
pgen
Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/14
07:30 am
pgen
Precigen, Inc. (NASDAQ:PGEN) is definitely on the radar of institutional investors who own 31% of the company [Yahoo! Finance]
Low
Report
Precigen, Inc. (NASDAQ:PGEN) is definitely on the radar of institutional investors who own 31% of the company [Yahoo! Finance]
11/25
06:53 am
pgen
Precigen Is Still A Buy After The Papzimeos Rally [Seeking Alpha]
Low
Report
Precigen Is Still A Buy After The Papzimeos Rally [Seeking Alpha]
11/14
02:07 pm
pgen
Vaxart, Precigen among biotech gainers after Q3 results [Seeking Alpha]
Low
Report
Vaxart, Precigen among biotech gainers after Q3 results [Seeking Alpha]
11/14
08:09 am
pgen
Precigen (NASDAQ:PGEN) had its price target raised by analysts at HC Wainwright from $8.50 to $9.00. They now have a "buy" rating on the stock.
High
Report
Precigen (NASDAQ:PGEN) had its price target raised by analysts at HC Wainwright from $8.50 to $9.00. They now have a "buy" rating on the stock.
11/14
12:10 am
pgen
Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... [Yahoo! Finance]
High
Report
Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... [Yahoo! Finance]